Cancer therapy meets p53

Research output: Contribution to journalReview article

Abstract

Although gene therapy and immunotherapy hold great promise for the future, cancer treatment now centers around surgical resection, radiation therapy, and chemotherapy. The therapeutic basis of surgical resection is obvious, but the same cannot be said for the other approaches. What accounts for the selective killing of malignant cells while normal cells are spared? It is clearly not simple differences in rates of replication. Why do cancers even of the same histologic type vary in their sensitivity to chemotherapy and radiotherapy? What accounts for the frustrating development of drug resistance? Recent findings provide a possible link between these questions and.

Original languageEnglish (US)
Pages (from-to)49-50
Number of pages2
JournalNew England Journal of Medicine
Volume331
Issue number1
DOIs
StatePublished - Jul 7 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Cancer therapy meets p53'. Together they form a unique fingerprint.

Cite this